Nat Med
Published

The role of placebo control in clinical trials for neurodegenerative diseases.

Authors

Arpan R Mehta, James R Carpenter, Jennifer M Nicholas, Jeremy Chataway, Bruce Virgo, Mahesh K B Parmar, Siddharthan Chandran, Suvankar Pal
Read More

Abstract

PMID:37710137 | DOI:

UK DRI Authors

Siddharthan Chandran

Prof Siddharthan Chandran

Director & CEO

Dissecting a genetic cause of ALS and FTD and identifying ways to help protect neurons

Prof Siddharthan Chandran
Suvankar Pal profile

Prof Suvankar Pal

Group Leader

Clinically active academic neurologist specialising in motor neuron disease

Prof Suvankar Pal